共 396 条
[1]
Kavey RE(2006)Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on CardiovascularDisease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research Circulation. 114 27
[2]
Allada V(1998)Determinants of atherosclerosis in the young. Pathobiological determinants of atherosclerosis in youth (PDAY) research group Am J Cardiol. 82 30T-6T
[3]
Daniels SR(1998)Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study N Engl J Med. 338 1650-6
[4]
Hayman LL(2016)Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES) Circulation 133 1067-1072
[5]
McCrindle BW(2013)Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J. 34 3478-3490
[6]
Newburger JW(2016)Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype Circulation. 134 9-19
[7]
Parekh RS(2014)Statins for children with familial hypercholesterolemia Cochrane Database Syst Rev. 7 CD006401-1162.e3
[8]
Steinberger J(2016)A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia J Clin Lipidol. 10 1153-668
[9]
McGill HC(2007)Statin treatment in children with familial hypercholesterolemia: the younger, the better Circulation. 116 664-2003
[10]
McMahan CA(2016)BMI at age 17 years and diabetes mortality in midlife: a nationwide cohort of 2.3 million adolescents Diabetes Care. 39 1996-222